Study to Evaluate ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract Surgery

Summary

The purpose of this study is to evaluate the ocular safety, tolerability, and efficacy of ISV-305 (dexamethasone in DuraSite® 2) compared with Vehicle in the treatment of inflammation and pain associated with cataract surgery.

Timeline

Start

2018-01-30

Primary completion

2019-04-17

Completion

2019-04-17

Outcome

Met primary endpoint

registry analysis (superiority test); ISV-305 vs Vehicle; p = 0.0005; Chi-squared, Corrected NCT03192137 ↗

Drugs

Indications